Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18).

For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.